| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.40B | 2.32B | 2.20B | 2.34B | 6.98B |
| Gross Profit | 4.83B | 2.32B | 1.76B | 1.86B | 6.57B |
| EBITDA | 2.83B | 0.00 | 1.42B | 169.20M | 4.71B |
| Net Income | 1.59B | 377.70M | -471.40M | -1.53B | 2.81B |
Balance Sheet | |||||
| Total Assets | 38.71B | 37.30B | 40.87B | 42.91B | 48.79B |
| Cash, Cash Equivalents and Short-Term Investments | 7.84B | 4.33B | 6.46B | 5.73B | 5.86B |
| Total Debt | 10.92B | 11.84B | 15.18B | 15.98B | 18.64B |
| Total Liabilities | 13.18B | 13.05B | 16.47B | 17.36B | 20.25B |
| Stockholders Equity | 22.34B | 21.15B | 21.27B | 22.36B | 25.08B |
Cash Flow | |||||
| Free Cash Flow | 2.07B | 1.86B | 1.59B | 3.92B | -1.53B |
| Operating Cash Flow | 2.14B | 1.88B | 1.65B | 3.99B | -1.47B |
| Investing Cash Flow | -358.50M | 209.60M | 871.10M | -121.20M | -596.60M |
| Financing Cash Flow | -1.69B | -4.17B | -1.75B | -3.78B | 596.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$6.42B | ― | 5.13% | 11.28% | -17.62% | -3.54% | |
72 Outperform | HK$3.54B | 7.07 | 11.00% | 6.92% | 2.65% | 16.91% | |
70 Outperform | HK$8.45B | 4.91 | 5.71% | 6.47% | 27.07% | 322.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | -2.69% | -8.21% | |
58 Neutral | HK$476.38M | -0.36 | -12.57% | 9.77% | 9.22% | -218.62% |